Clinical Utility of Striational Antibodies in Paraneoplastic and Myasthenia Gravis Paraneoplastic Panels.
Shahar ShellyJohn R MillsDivyansu DubeyAndrew McKeonAnastasia ZekeridouSean J PittockC Michel HarperElie NaddafMargherita MiloneJay MandrekarChristopher J KleinPublished in: Neurology (2021)
This study provides Class II evidence that the presence of StrAbs do not accurately identify patients with malignancy or neurological phenotypes.